Mergers & Acquisitions

Filter

Current filters:

None

Popular Filters

12 to 36 of 919 results

Roche continues spending spree, with acquisition of French biotech firm Trophos

Roche continues spending spree, with acquisition of French biotech firm Trophos

16-01-2015

Continuing its recent spate of deal-making, Swiss pharma giant Roche has agreed to acquire Trophos, a…

BiotechnologyMergers & AcquisitionsolesoximeRare diseasesRocheSwitzerlandTrophos

GlobalData believes Shire-NPS deal to be 'robust'

GlobalData believes Shire-NPS deal to be 'robust'

15-01-2015

Ireland-headquartered drugmaker Shire’s deal to acquire NPS Pharmaceuticals is ‘robust’, according…

GattexGlobalDataMergers & AcquisitionsNatparaNPS PharmaceuticalsPharmaceuticalRare diseasesResearchShire

Low dollar tipped to stimulate biotech investment in Australia

15-01-2015

Analyst commentary suggests the devaluation of the Australian dollar during 2014, has left biotech in…

ActinogenAustraliaBenitec BiopharmaBiotechnologyFinancialMergers & AcquisitionsSirtex Medical

2014 a memorable year for M&A activity in pharma sector

2014 a memorable year for M&A activity in pharma sector

15-01-2015

2014 was a busy year for merger and acquisition activity in the pharmaceutical industry, but will be…

GlobalMergers & AcquisitionsPfizerPharmaceuticalShire

Regado and Tobira to merge to create leading NASH company

Regado and Tobira to merge to create leading NASH company

14-01-2015

The USA’s Regado Biosciences and privately-held Tobira Therapeutics have entered into a definitive…

Mergers & AcquisitionsNephrology and HepatologyPharmaceuticalRegadoTobira TherapeuticsUSA

Qiagen acquires unit of Enzymatics and agrees partnership with ArcherDX

Qiagen acquires unit of Enzymatics and agrees partnership with ArcherDX

12-01-2015

Netherlands-based company Qiagen has acquired the Enzyme Solutions Unit of privately-held US company…

ArcherDXBiotechnologyEnzymaticsGeneticsMergers & AcquisitionsNetherlandsQiagen

Shire to spend $5.2 billion to buy NPS Pharma

Shire to spend $5.2 billion to buy NPS Pharma

12-01-2015

Recently jilted Ireland-headquartered Shire says it is to acquire NPS Pharmaceuticals, confirming recent…

BiotechnologyEuropeGattexMergers & AcquisitionsNatparaNPS PharmaceuticalsRare diseasesRevestiveShire

AMRI to acquire Aptuit businesses units for $60 million

AMRI to acquire Aptuit businesses units for $60 million

09-01-2015

US-based drug development and discovery company Aptuit has divested its aseptic clinical manufacturing…

Albany Molecular ResearchAptuitMergers & AcquisitionsPharmaceuticalProductionUSA

Horizon Discovery agrees to acquire Haplogen Genomics in $9 million deal

Horizon Discovery agrees to acquire Haplogen Genomics in $9 million deal

08-01-2015

Life science research tool supplier Horizon Discovery Group has agreed to acquire Haplogen Genomics,…

BiotechnologyEvent horizonHaplogen GenomicsHorizon Discovery GroupMergers & Acquisitions

Valneva to acquire Dukoral vaccine from Crucell

07-01-2015

France-based biotech firm Valneva has entered into an agreement with Crucell Holland (part of Johnson…

CrucellDukoralJohnson & JohnsonMergers & AcquisitionsPharmaceuticalVaccinesValneva

Cardio3 BioSciences acquires Celdara’s OnCyte division

Cardio3 BioSciences acquires Celdara’s OnCyte division

06-01-2015

Belgian biotech firmCardio3 BioSciences has acquired OnCyte, the oncology division of privately-held…

BiotechnologyCardio3 BioSciencesCeldara MedicalMergers & AcquisitionsOncologyOnCyte

Pfizer gains rights to CMV vaccine with controlling stake in Redvax

Pfizer gains rights to CMV vaccine with controlling stake in Redvax

06-01-2015

US pharma giant Pfizer has acquired a controlling interest in Redvax GmbH, a spin-off from Redbiotec,…

Anti-viralsMergers & AcquisitionsPfizerPharmaceuticalRedbiotechRedvaxVaccines

Walgreens and Alliance Boots complete Step 2 of merger

Walgreens and Alliance Boots complete Step 2 of merger

04-01-2015

USA-headquartered Walgreen and Europe’s Alliance Boots GmbH on January 1 completed Step 2 of their…

Alliance BootsEuropeMergers & AcquisitionsPharmaceuticalUSAWalgreensWalgreens Boots Alliance

Top five health care trends of 2014 identified by Kalorama

Top five health care trends of 2014 identified by Kalorama

30-12-2014

Kalorama Information has identified its "Top Five Trends in Healthcare in 2014." The healthcare market…

GlobalHealthcareMergers & AcquisitionsPharmaceuticalProduction

Reckitt Benckiser demerger goes through, creating Indivior as pharma arm

Reckitt Benckiser demerger goes through, creating Indivior as pharma arm

23-12-2014

The UK-based consumer goods giant Reckitt Benckiser Group has demerged what was once its USA-based pharma…

FinancialIndivior PLCMergers & AcquisitionsNeurologicalPharmaceuticalReckitt BenckiserUSA

Janssen partners with MacroGenics in up to $625 million deal

Janssen partners with MacroGenics in up to $625 million deal

23-12-2014

Shares of US biotech firm MacroGenics rocketed 11.7% to a 10-month high of $38.58 yesterday, on the news…

BiotechnologyGlobalJanssen BiotechJohnson & JohnsonLicensingMacroGenicsMergers & AcquisitionsMGD011Oncology

Vanda and Novartis to settle arbitration, with rights to Fanapt returned

23-12-2014

US biopharma firm Vanda Pharmaceuticals says it has reached a settlement agreement with Swiss drug major…

FanaptLegalLicensingMergers & AcquisitionsNeurologicalNovartisPharmaceuticalVanda Pharmaceuticals

FTC puts conditions on Eli Lilly’s proposed acquisition of Novartis Animal Health

23-12-2014

US pharma major Eli Lilly has agreed to divest its Sentinel product line of medications for treating…

Eli LillyMergers & AcquisitionsNovartisPharmaceuticalUSA

Bina Technologies is acquired by Roche

20-12-2014

Swiss pharma giant Roche has acquired Bina Technologies, a privately held company based in Redwood City,…

Bina TechnologiesBiotechnologyMergers & AcquisitionsRoche

Merck & Co in up to $375 million deal to acquire OncoEthix

Merck & Co in up to $375 million deal to acquire OncoEthix

19-12-2014

US pharma giant Merck & Co said yesterday that it has acquired, through a subsidiary, Swiss-based privately…

BiotechnologyMerck & CoMergers & AcquisitionsOncoEthixOncologyOTX015

Roche to acquire Austrian next-generation antibody firm Dutalys

Roche to acquire Austrian next-generation antibody firm Dutalys

19-12-2014

Swiss pharma giant Roche has agreed to acquire Dutalys, a privately held biotechnology company based…

BiotechnologyDutalysDutaMabMergers & AcquisitionsOncologyRoche

12 to 36 of 919 results

Back to top